ಟ್ವೀಟ್ಗಳು
- ಟ್ವೀಟ್ಗಳು
- ಟ್ವೀಟ್ಗಳು & ಪ್ರತಿಕ್ರಿಯೆಗಳು
- ಮಾಧ್ಯಮ
@ASCO ತಡೆಹಿಡಿಯಲಾಗಿದೆ
ನೀವು ಖಚಿತವಾಗಿಯೂ ಈ ಟ್ವೀಟ್ಗಳನ್ನು ನೋಡಲು ಬಯಸುವಿರಾ? ಟ್ವೀಟ್ಗಳನ್ನು ನೋಡುವುದು @ASCO ಅವರನ್ನು ತಡೆತೆರವುಗೊಳಿಸುವುದಿಲ್ಲ.
-
Earn
#MOC and#CME credits with#ASCOU's January 2017 MOC App, now with 40 self-assessment questions http://bit.ly/2lhrN2d -
World-renowned researchers will promote innovation in quality measurement & health services research at
#ASCOQLTY - http://bit.ly/1jiYx23 -
Submit research to advance precision oncology & define genomics-driven clinical care of patients with cancer: http://bit.ly/2dzjM4d
#JCOPO -
Couldn't make it to
#GU17? Watch recorded presentations with#ASCOU's Virtual Meeting http://bit.ly/2kK1FvT -
Submit an article to
@JGO_ASCO's#openaccess Journal of Global Oncology: http://bit.ly/1ZGMzlv -
Apply today to attend the International Clinical Trials Workshop in Athens, Greece, May 19-20 http://bit.ly/2jU0NDV
-
Just launched: Pancreatic Cancer Adjuvant Therapy
#ASCOU Tumor Board http://bit.ly/2lhlUSk -
New in
@JOP_ASCO: patient reported outcomes associated w/ oral oncolytic therapy are evaluated using#QOPI measures http://bit.ly/2lTsN9G -
Learn how to implement & measure Team-Based Care on
#ASCOU (MOC & CME available) http://bit.ly/2k0xa0O -
Should localized
#prostatecancer be treated with surgery, radiation, or active surveillance? http://bit.ly/2ktRVGT#GU17pic.twitter.com/2NaPsafliN
-
#ASCOU's new Biostatistics course covers the practical uses of biostatistics in oncology http://bit.ly/2hfLEM6 -
Agree w
@JBrugarolas@UTSWNews. Nivo benefit is in poor risk pts. Note that Cabo has benefit across subgroups!@ASCO#GU17@DrChoueiripic.twitter.com/QpdtMUgYd3
-
Active Surveillance for Small Renal Masses Is Non-Inferior to Primary Intervention: http://bit.ly/2lW4mf5
#GU17pic.twitter.com/p1O0640ZLy
-
Update in noninvasive imaging in muscle-invasive and metastatic
#bladdercancer http://bit.ly/2lSpP5e#GU17 -
Dr Lucky Lara reviews the oral abstracts in
#gu17@ASCO@SWOG@montypal@DrChoueiri@sonpavde@SupportingSWOG@UCDavisHealth @caitano_mpic.twitter.com/4AwdsbGqul
-
Genetic Testing Can Predict Metastasis and Death in Prostate Cancer http://www.curetoday.com/articles/genetic-testing-can-predict-metastasis-and-death-in-prostate-cancer …
#GU17@DanaFarber -
The pros and cons of new treatments for patients with oligometastatic
#prostatecancer http://bit.ly/2llOUrN#GU17 -
The evolving role of active surveillance in small renal tumors http://bit.ly/2ktGEX2
#GU17 -
Learn to respond to 10 types of oncologic emergencies in
#ASCOU's Oncologic Emergencies Management course http://bit.ly/2dxrj5e -
Attend the Multidisciplinary Cancer Management Course in Uyo, Nigeria from March 14-17http://bit.ly/2jTV6G3
ಲೋಡಿಂಗ್ ಸಮಯ ಸ್ವಲ್ಪ ತೆಗೆದುಕೊಳ್ಳುತ್ತಿರುವಂತೆನಿಸುತ್ತದೆ.
Twitter ಸಾಮರ್ಥ್ಯ ಮೀರಿರಬಹುದು ಅಥವಾ ಕ್ಷಣಿಕವಾದ ತೊಂದರೆಯನ್ನು ಅನುಭವಿಸುತ್ತಿರಬಹುದು. ಮತ್ತೆ ಪ್ರಯತ್ನಿಸಿ ಅಥವಾ ಹೆಚ್ಚಿನ ಮಾಹಿತಿಗೆ Twitter ಸ್ಥಿತಿಗೆ ಭೇಟಿ ನೀಡಿ.
ASCO
Sumanta Pal
Neeraj Agarwal
CURE Magazine